Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
A safety-centric perspective on innovation and risk in the use of artificial intelligence in genomics
0
Zitationen
10
Autoren
2026
Jahr
Abstract
Adopting a safety-centric approach, this article explores how generative artificial intelligence (AI), and more specifically, foundation models for biological sequences, can exacerbate data quality issues, technical biases, and dual-use potential, particularly in critical applications such as clinical genetics, precision medicine, and pathogen engineering. This work centres on how misuse risks emerge throughout the innovation pipeline and how these intersect with the growing accessibility of generative genomic models. Particular attention is given to dual-use governance and infrastructure hardening in sequence analysis workflows. The work aims to provide scientists, regulators, and policymakers with a toolkit to discuss beneficial innovation in genomic AI while maintaining robust safeguards against harm and misuse.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.764 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.674 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 8.234 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.898 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.